Concepedia

Kathleen F. Kadow

KF

Statistics

Publications

14

Citations

718

H-Index

14

Active since

1991

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Kathleen F. Kadow is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1991–2009

14

Publications

14

Niruriside, a New HIV REV/RRE Binding Inhibitor from <i>Phyllanthus niruri</i>

Jingfang Qian‐Cutrone, Stella Huang, John J. Trimble et al. · Journal of Natural Products · 1996 · 93 citations

, , +12

Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity

Gary R. Braslawsky, Kathleen F. Kadow, Jay O. Knipe et al. · Cancer Immunology Immunotherapy · 1991 · 80 citations · Full text

, , +5

Fundamental structure–Activity relationships associated with a new structural class of respiratory syncytial virus inhibitor

Kuo-Long Yu, Yi Zhang, Rita L. Civiello et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 69 citations

, , +11

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Kuo‐Long Yu, Ny Sin, Rita L. Civiello et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 68 citations

, , +6

Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.

Pamela A. Trail, David Willner, Jay O. Knipe et al. · PubMed · 1997 · 56 citations

, , +19

1–5 of 14